Abstract:OBJECTIVE:To evaluate the feasibility of the chitosan-poly (lactide-co-glycolide) (PLGA) double-walled microspheres for sustained release of bioactive nerve growth factor (NGF) in vitro. METHODS:NGF loaded chitosan-PLGA double-walled microspheres were prepared by emulsion-ionic method with sodium tripolyphosphate (TPP) as an ionic cross-linker. The double-walled microspheres were cross-linked by different concentrations of TPP [1%, 3%, 10% ( W/ V)]. NGF loaded PLGA microspheres were also prepared. The outer and inner structures of double-walled microspheres were observed by light microscopy, scanning electron microscopy, confocal laser scanning microscopy, respectively. The size and distribution of microspheres and fourier transform infra red spectroscopy (FT-IR) were analyzed. PLGA microspheres with NGF or chitosan-PLGA double-walled microspheres cross-linked by 1%, 3%, and 10%TPP concentration (set as groups A, B, C, and D respectively) were used to determine the degradation ratio of microspheres in vitro and the sustained release ratio of NGF in microspheres at different time points. The bioactivity of NGF (expressed as the percentage of PC12 cells with positive axonal elongation reaction) in the sustained release solution of chitosan-PLGA double-walled microspheres without NGF (set as group A1) was compared in groups B, C, and D. RESULTS:The chitosan-PLGA double-walled microspheres showed relative rough and spherical surfaces without aggregation. Confocal laser scanning microscopy showed PLGA microspheres were evenly uniformly distributed in the chitosan-PLGA double-walled microspheres. The particle size of microspheres ranged from 18.5 to 42.7 μm. The results of FT-IR analysis showed ionic interaction between amino groups and phosphoric groups of chitosan in double-walled microspheres and TPP. In vitro degradation ratio analysis showed that the degradation ratio of double-walled microspheres in groups B, C, and D appeared faster in contrast to that in group A. In addition, the degradation ratio of double-walled microsphere in groups B, C, and D decreased when the TPP concentration increased. There were significant differences in the degradation ratio of each group ( P<0.05). In vitro sustained release ratio of NGF showed that when compared with PLGA microspheres in group A, double-walled microspheres in groups B, C, and D released NGF at a relatively slow rate, and the sustained release ratio decreased with the increase of TPP concentration. Except for 84 days, there was significant difference in the sustained release ratio of NGF between groups B, C, and D ( P<0.05). The bioactivity of NGF results showed that the percentage of PC12 cells with positive axonal elongation reaction in groups B, C, and D was significantly higher than that in group A1 ( P<0.05). At 7 and 28 days of culture, there was no significant difference between groups B, C, and D ( P>0.05); at 56 and 84 days of culture, the percentage of PC12 cells with positive axonal elongation reaction in groups C and D was significantly higher than that in group B ( P<0.05), and there was no significant difference between groups C and D ( P>0.05). CONCLUSION:NGF loaded chitosan-PLGA double-walled microspheres have a potential clinical application in peripheral nerve regeneration after injury.

Preparation and in vitro compatibility of transforming growth factor beta 1 loaded chitosan microspheres

Preparation of Chitosan Scaffolds Controlling-released bFGF and its Effect on Cell Culture

In Vitro Study of TGF-β1 Loaded Chitosan Microspheres

The Production of Transforming Growth Factor - Beta1 - Loaded Chitosan Microspheres and the Effect of Controlled Release of TGF - Β1

In Vivo Validation of Biological Responses of Bfgf Released from Microspheres Formulated by Blending Poly-Lactide-co-Glycolide and Poly(ethylene Glycol)-Grafted-chitosan in Hamster Cheek Pouch Microcirculatory Models

Chitosan-polycaprolactone copolymer microspheres for transforming growth factor-β1 delivery.

Chitosan-Polylactide/Hyaluronic Acid Complex Microspheres As Carriers For Controlled Release Of Bioactive Transforming Growth Factor-Beta 1

Chitosan Scaffold Containing Microspheres As Carriers for Controlled TGF-βI Delivery for Cartilage Tissue Engineering in Vitro

Enhanced Bioactivity of Transform Growth Factor-Β1 from Sulfated Chitosan Microspheres for in Vitro Chondrogenesis of Mesenchymal Stem Cells

The Preliminary Study of Temperature-Responsive Chitosan Gel Combined withDrug-Loaded Chitosan Microspheres

Preparation and improvement of release behavior of chitosan microspheres containing insulin.

Biodegradable Chitosan Scaffolds Containing Microspheres As Carriers for Controlled Transforming Growth Factor-Beta1 Delivery for Cartilage Tissue Engineering.

Preparation and characterization of chitosan microspheres for controlled release of synthetic oligopeptide derived from BMP-2.

Biocompatibility of sustained-releasing microspheres loading chitosan scaffolds

[The fabrication and related properties study of chitosan-poly (lactide-co-glycolide) double-walled microspheres loaded with nerve growth factor].

New chitosan hydrochloride microspheres: Fabrication, property and in Vitro evaluation

Chitosan Loaded Pig Thymosin Microspheres for Drug Delivery

Ionically cross-linked chitosan microspheres for controlled release of bioactive nerve growth factor.

Preparation of Uniform-sized Chitosan Microspheres and Application As Carriers for Protein Drugs

Preparation and in vitro Release of Multi layer Alginate Chitosan Microspheres Loading VEGF and Vancomycin

The Preparation and Characterization of Chitooligosaccharide–Polylactide Polymers, and in Vitro Release of Microspheres Loaded with Vancomycin